Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Down syndrome is caused by an error in cell division during development. Individuals receive three copies of chromosome 21 instead of the typical two copies, resulting in duplicates of the genes ...

Scientists have reached a milestone in an ambitious initiative to chart how the many types of brain cells emerge and mature ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

A multibillion-dollar project reveals critical moments during pregnancy, and even after birth, when the risk of neurological ...

The Cayenne Electric will be launched in a few weeks, featuring innovative high-voltage technology. With a function-integrated battery, powerful dual cooling, intelligent thermal management and robust ...

PELSA, a high-throughput tool that rapidly detects protein–ligand interactions across hundreds of samples daily. By ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue ...

The seven-year project, led by Professor Steffen Scholpp, Cell and Developmental Biology, together with Professor Kyle Wedgwood, Computational Biology, will explore the role of cytonemes - long, thin ...

New research shows that the superior colliculus, a primitive brain region, can independently interpret visual information.

Emerging gene therapy administered through a one-time subretinal injection marks a major milestone for the inherited retinal disease community RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE ...

The Chinese car maker, BYD, is about to launch its ‘Denza’ luxury sub-brand in the UK, and the Z9GT is the first offering.